| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.3 | 2e-06 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | -0.27 | 3e-05 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.26 | 6e-05 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.25 | 0.0006 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | -0.25 | 0.0001 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | -0.24 | 0.2 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | -0.23 | 0.0004 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | -0.23 | 0.2 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.22 | 0.0006 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | -0.21 | 0.0009 |